Susan Brown-Skrobot

Title: The Innovative Contributions of Susan Brown-Skrobot

Introduction

Susan Brown-Skrobot is a notable inventor based in Hamilton, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that combat antibiotic resistance. With a total of 2 patents, her work has the potential to impact public health positively.

Latest Patents

One of her latest patents focuses on the "Inhibition of expression of beta-lactamase using esters of fatty acid." This patent describes a class of chemical compounds comprising fatty acid ester derivatives that inhibit the production of beta-lactamase by infectious bacteria. These inhibitors have been shown to slow down the resistance of certain bacterial strains to beta-lactam antibiotics, such as penicillin. By interfering with the transcription of the beta-lactamase gene, these compounds prevent the expression of beta-lactamase, allowing for effective treatment of infections caused by otherwise resistant bacteria.

Career Highlights

Throughout her career, Susan has worked with prominent organizations, including Johnson & Johnson GmbH and the Public Health Research Institute. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to significant advancements in medical research.

Collaborations

Susan has collaborated with esteemed colleagues such as Richard P. Novick and Steven J. Projan. These partnerships have further enriched her research and development efforts in combating antibiotic resistance.

Conclusion

Susan Brown-Skrobot's innovative work in the field of biochemistry highlights her commitment to addressing critical health challenges. Her patents and collaborations reflect her dedication to improving treatment options for bacterial infections.